Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Promazi | ASPIRO PHARMA LIMITED | Solution for injection | Jan 1, 2025 | Generic |
| Tadalafil SPI | Jubilant Generics Limited | Film-coated tablet | Jan 1, 2025 | Generic |
| Carfilzomib BOS | Natco Pharma Limited | Powder for solution for injection/infusion | Jan 1, 2025 | Generic |
| Inveris | PHARMASCIENCE INC. | Suspension for injection in pre-filled syringe | Jan 1, 2025 | Generic |
| Carfilzomib BOS | Natco Pharma Limited | Powder for solution for injection/infusion | Jan 1, 2025 | Generic |
| Pinolanz | ASPIRO PHARMA LIMITED | Powder for injection | Jan 1, 2025 | Generic |
| Sildenafil Amarox | Hetero Labs Limited Unit – V | Powder for oral suspension | Jan 1, 2025 | Generic |
| Tadalafil SPI | Jubilant Generics Limited | Film-coated tablet | Jan 1, 2025 | Generic |
| Rufzel | Hetero Labs Limited Unit – III | Tablet | Jan 1, 2025 | Generic |
| Betaten | NATIONAL PHARMACEUTICAL INDUSTRIES CO | Film-coated tablet | Jan 1, 2025 | Generic |
| Endura | Med city | Film-coated tablet | Jan 1, 2025 | Generic |
| Amiroic | M/s Annora Pharma Private Limited | Oral solution | Jan 1, 2025 | Generic |
| Docetere | Hetero Labs Limited Unit – V | Solution for infusion | Jan 1, 2025 | Generic |
| Endura | Med city | Film-coated tablet | Jan 1, 2025 | Generic |
| Betaten | NATIONAL PHARMACEUTICAL INDUSTRIES CO | Film-coated tablet | Jan 1, 2025 | Generic |
| Nucala | Glaxo Operations UK Ltd | Solution for injection in pre-filled syringe | Jan 1, 2025 | Biological |
| Risek Plus | Gulf Pharmaceutical Industries (Julphar) | Capsule | Jan 1, 2025 | Generic |
| Pafinur | ITALFARMACO SA | Oral solution | Jan 1, 2025 | NCE |
| Promazi | M/s Annora Pharma Private Limited | Tablet | Jan 1, 2025 | Generic |
| Acura | UNIVERSAL FARMA SL | Concentrate for solution for infusion | Jan 1, 2025 | Biological |
